Cargando…

ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining

PURPOSE: The dysregulation of arrestin domain containing 3 (ARRDC3) has an important effect on oncogenesis and tumor progression in many cancers, including renal cell carcinoma and breast cancer. However, the role of ARRDC3 in ovarian cancer (OC) has not been reported. METHODS: The present study exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanli, Tian, Dan, Chen, Xiaoqi, Tang, Zhi, Li, Kuina, Huang, Zhijiong, Fu, Yong, Feng, Yanying, Yang, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997607/ https://www.ncbi.nlm.nih.gov/pubmed/33790626 http://dx.doi.org/10.2147/IJGM.S302012

Ejemplares similares

Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer
por: Huang, Zhijiong, et al.
Publicado: (2023)

A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer
por: Zhang, Mengjun, et al.
Publicado: (2022)

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
por: Zhang, Mengjun, et al.
Publicado: (2022)

Divergent regulation of α-arrestin ARRDC3 function by ubiquitination
por: Wedegaertner, Helen, et al.
Publicado: (2023)

Arrdc4‐dependent extracellular vesicle biogenesis is required for sperm maturation
por: Foot, Natalie J., et al.
Publicado: (2021)

ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4
por: Draheim, K M, et al.
Publicado: (2010)

Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells
por: Soung, Young Hwa, et al.
Publicado: (2014)

Erratum: Arrdc4‐dependent extracellular vesicle biogenesis is required for sperm maturation
Publicado: (2021)

ARRDC5 expression is conserved in mammalian testes and required for normal sperm morphogenesis
por: Giassetti, Mariana I., et al.
Publicado: (2023)

Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics
por: Alur, Varun Chandra, et al.
Publicado: (2019)

ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score
por: Oh, Jong Jin, et al.
Publicado: (2021)

K‐29 linked ubiquitination of Arrdc4 regulates its function in extracellular vesicle biogenesis
por: Farooq, Ammara Usman, et al.
Publicado: (2022)

circARRDC3 contributes to interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells via the miR-375/KLF4 axis
por: Wang, Tao, et al.
Publicado: (2021)

The α-arrestin ARRDC3 mediates ALIX ubiquitination and G protein–coupled receptor lysosomal sorting
por: Dores, Michael R., et al.
Publicado: (2015)

A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer
por: Zhu, Tao, et al.
Publicado: (2017)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Immune-Related Genes’ Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer
por: Ding, Bo, et al.
Publicado: (2023)

B7-H7 is a prognostic biomarker in epithelial ovarian cancer
por: Fu, Yuanyuan, et al.
Publicado: (2020)

MicroRNA miR-124-3p suppresses proliferation and epithelial–mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1)
por: Zhao, Qiannan, et al.
Publicado: (2022)

High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer
por: Zhang, Beilei, et al.
Publicado: (2022)

DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining
por: Chen, Jianlin, et al.
Publicado: (2021)

circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
por: Cao, Chenyuan, et al.
Publicado: (2023)

ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65
por: Meng, Jun, et al.
Publicado: (2017)

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
por: Le Page, Cécile, et al.
Publicado: (2010)

GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer
por: Feng, Yanling, et al.
Publicado: (2015)

A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer
por: Qiu, Yan, et al.
Publicado: (2021)

Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments
por: Chang, Xiaoying, et al.
Publicado: (2021)

Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023)

GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway
por: Feng, Ying, et al.
Publicado: (2021)

TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer
por: Liu, T, et al.
Publicado: (2013)

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
por: Pénzváltó, Zsófia, et al.
Publicado: (2014)

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2021)

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
por: Fan, Lijun, et al.
Publicado: (2016)

Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
por: Hu, Yingchao, et al.
Publicado: (2019)

MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer
por: Dong, Si Yang, et al.
Publicado: (2020)

CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
por: Hu, Pan, et al.
Publicado: (2023)

Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer
por: Coveney, Clare, et al.
Publicado: (2015)

Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer
por: Wu, Wenjuan, et al.
Publicado: (2021)

Selective Inhibitors of Nuclear Export (SINE) compounds block proliferation and migration of triple negative breast cancer cells by restoring expression of ARRDC3
por: Soung, Young Hwa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4kskgrgm2260jmjiup0306lrq3